Breast fine-needle aspiration cytology performance in the high-risk screening population
Open Access
- 29 May 2013
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 121 (10), 561-567
- https://doi.org/10.1002/cncy.21308
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Cancer Epidemiology, Biomarkers & Prevention, 2011
- Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A reviewJournal of Clinical Pathology, 2011
- Annual screening strategies in BRCA1 and BRCA2 gene mutation carriersCancer, 2011
- Conclusiveness of fine needle aspiration in 2419 histologically confirmed benign and malignant breast lesionsThe Breast, 2011
- Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomyBreast Cancer Research and Treatment, 2011
- BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening StudyJournal of Clinical Oncology, 2010
- The value of fine needle aspiration biopsy in the diagnosis and prognostic assessment of palpable breast lesionsDiagnostic Cytopathology, 2010
- Comparison of accuracy of diagnostic modalities for evaluation of breast cancer with review of literatureDiagnostic Cytopathology, 2009
- A comparision of aspiration cytology and core needle biopsy according to tumor size of suspicious breast lesionsDiagnostic Cytopathology, 2007
- The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesionsJournal of Clinical Pathology, 2001